Follow the progress of Hemolens Diagnostics
This website contains information intended only for persons professionally dealing with medical devices (e.g. for persons performing medical professions, for persons dealing with the distribution of medical devices). Please confirm that you are a medical device professional to proceed.
Follow the progress of Hemolens Diagnostics
September 2, 2022
Cardiolens FFR-CT Pro® is a precise diagnostic test, supporting doctors in diagnosing patients with suspected ischemic heart disease.
Cardiolens FFR-CT Pro® technology analyzes data from two non-invasive diagnostic methods: Cardiac Computed Tomography Angiography (CCTA) combined with Continuous Non-Invasive Blood Pressure (CNBP) to create a precision in personalized diagnostics of ischemic heart disease that has not been achieved before on the market.
Using this technology allows for precise and accurate anatomical and functional assessment of the coronary arteries by creating a digital twin of the patient’s coronary vessels (3D vascular models), while providing the results of a virtual fractional flow reserve (FFR) in the coronary arteries (LAD, RCA, LCX).
An invaluable benefit of using Cardiolens FFR-CT Pro® technology is eliminating hospital stay, reducing patient stress and supporting physicians’ therapeutic decisions.
Intended Use:
Cardiolens FFR-CT Pro is a coronary physiologic simulation software for the clinical quantitative and qualitative analysis of previously acquired Coronary Computed Tomography Angiography (CCTA) and optionally with Continuous Non-invasive Blood Pressure (CNBP) data for assessment of patients with suspected Chronic Coronary Syndromes (CCS). It provides hemodynamic diagnostic factor FFR-CT (Fractional Flow Reserve with Computed Tomography), a mathematically derived quantity, computed from simulated pressure, velocity and blood flow information obtained from a 3D computer model generated from static coronary CT images and optionally from CNBP measurement. The factor FFR-CT at the output of Cardiolens FFR-CT Pro device is intended to support the functional evaluation of coronary artery disease. The Cardiolens FFR-CT Pro outputs are provided to support qualified clinicians to aid in the evaluation and assessment of coronary arteries. The results of Cardiolens FFR-CT Pro are intended to be used by qualified clinicians in conjunction with the patient’s clinical history, symptoms, and other diagnostic tests, as well as the clinician’s professional judgment.